Please login to the form below

Not currently logged in
Email:
Password:

Rare disease UK

This page shows the latest Rare disease UK news and features for those working in and with pharma, biotech and healthcare.

GSK hands rare disease assets over to Orchard

GSK hands rare disease assets over to Orchard

GSK hands rare disease assets over to Orchard. The UK pharma group will take a 19.9% stake in its ex-rival. ... GlaxoSmithKline has decided the future of its rare disease business - and it lies outside the company.

Latest news

  • emotive partners with Rare Disease UK for public awareness campaign emotive partners with Rare Disease UK for public awareness campaign

    emotive partners with Rare Disease UK for public awareness campaign. Will launch the campaign ahead of next month's Rare Disease Day. ... Partnering with emotive, Rare Disease UK hopes that the agency can bring creativity to their campaign.

  • Amicus gets NICE green light for Fabry drug Amicus gets NICE green light for Fabry drug

    The National Institute of Health and Care Excellence has given its blessing to Amicus' oral therapy for Fabry disease, a rare genetic disorder. ... The UK's cost-effectiveness regulator has published final guidance endorsing the use of Galafold

  • Pharma companies back Rare Disease Day Pharma companies back Rare Disease Day

    In the UK, Rare Disease Day 2014 is focusing on the implementation of the UK Strategy for Rare Diseases, launched last November. ... UK staff, in addition to taking part in the torch relay, will submit articles to the national Rare Disease Day supplement.

  • Rare disease strategy for the UK launched Rare disease strategy for the UK launched

    Rare disease strategy for the UK launched. Aims to improve understanding and boost research. ... Rare disease research in the UK. Another key strand to the strategy seeks to position the UK as a world leader in research and development to improve the

  • GSK antisense drug fails muscular dystrophy trial GSK antisense drug fails muscular dystrophy trial

    We appreciate that these results will be disappointing for boys with DMD and their families," said Carlo Russo, head of GSK's rare disease R&D unit. ... UK medical charity the Multiple Dystrophy Campaign described the findings as a "heavy blow", although

More from news
Approximately 1 fully matching, plus 11 partially matching documents found.

Latest Intelligence

  • Accelerating diagnosis in rare disease Accelerating diagnosis in rare disease

    Accelerating diagnosis in rare disease. Timely diagnosis in rare disease is one of the fundamental unmet needs for patients, healthcare professionals (HCPs) and biopharma. ... However, as referring and prescribing doctors in rare disease can be small in

  • Accelerating diagnosis in rare disease Accelerating diagnosis in rare disease

    Accelerating diagnosis in rare disease. Timely diagnosis in rare disease is one of the fundamental unmet needs for patients, healthcare professionals (HCPs) and biopharma. ... However, as referring and prescribing doctors in rare disease can be small in

  • A rare talent A rare talent

    As part of his efforts in this area Sebastian chairs the Rare Disease Strategy Group with UK industry body the ABPI. ... Making sense of change. From a newly enlarged company to new premises, to - perhaps - new HTA arrangements for rare disease

  • The distressing impact of rare diseases The distressing impact of rare diseases

    The company, which has a significant stake in the area, conducted online surveys in January among more than 1, 000 US/UK rare disease patients, carers, doctors, payers, government/institution representatives ... A UK patient with mixed connective tissue

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 4 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
BASTARD . LONDON

BASTARD . LONDON collaborates with you to amplify brand ideas into a visual brand language that resonates and engages with...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics